Valuation: Zai Lab Limited

Market Cap 2.65B 2.29B 2.15B 1.96B 3.69B 253B 3.75B 25.2B 9.86B 126B 9.94B 9.73B 422B P/E 2026 *
-10.4x
P/E 2027 * -11x
Enterprise Value 2.19B 1.9B 1.78B 1.62B 3.05B 209B 3.1B 20.85B 8.15B 105B 8.22B 8.05B 349B EV / Sales 2026 *
5.18x
EV / Sales 2027 * 3.96x
Free-Float
94.05%
Yield 2026 *
-
Yield 2027 * -
1 day+10.31%
1 week+43.01%
Current month+42.31%
1 month+26.89%
3 months+39.78%
6 months+32.99%
Current year+47.39%
1 week 18.22
Extreme 18.22
26.66
1 month 17.92
Extreme 17.92
26.66
Current year 15.96
Extreme 15.96
26.66
1 year 15.96
Extreme 15.96
36.77
3 years 13.48
Extreme 13.48
44.34
5 years 13.48
Extreme 13.48
152.82
10 years 13.48
Extreme 13.48
193.54
Manager TitleAgeSince
Chief Executive Officer 61 2014-03-31
Director of Finance/CFO 58 2023-07-06
President 62 2022-11-30
Director TitleAgeSince
Chairman 61 2014-03-31
Director/Board Member 83 2016-12-31
Director/Board Member 75 2016-12-31
Date Insider Type Main position Quantity % Market Cap.
7/2/26 Other

Chief Executive Officer

-43,480 0.0038%
7/2/26 Fiscal year

Chief Executive Officer

106,837 0.0094%
7/2/26 Other

Chief Executive Officer

803,930 0.0707%
Change 5-day change 1-year change 3-year change Capi.($)
+10.31%+43.01%-25.63%+1.01% 2.65B
-1.37%+4.97%+41.56%+0.50% 80.69B
+2.55%+13.07%+2.40%+30.48% 51.22B
+0.49%+2.17%+22.60%+177.89% 49.58B
+2.87%+11.29%-46.98%-47.72% 45.5B
-1.56%+1.03%+56.03%-24.22% 30.6B
-0.39%+2.23%+54.45%+84.81% 24.64B
+1.27%+9.85%+131.89%-39.60% 23.88B
-1.80%+11.10%+4.71%+196.74% 21.59B
-5.89%+34.09%-0.99%+792.56% 17.09B
Average +0.51%+165.94%+24.01%+117.24% 34.74B
Weighted average by Cap. +0.01%+268.88%+24.99%+76.12%

Financials

2026 *2027 *
Net sales 423M 366M 343M 313M 589M 40.36B 599M 4.02B 1.57B 20.19B 1.59B 1.55B 67.36B 573M 496M 464M 424M 797M 54.64B 811M 5.45B 2.13B 27.33B 2.15B 2.1B 91.2B
Net income -240M -208M -195M -178M -335M -22.95B -341M -2.29B -895M -11.48B -903M -883M -38.3B -178M -154M -144M -132M -248M -16.99B -252M -1.69B -663M -8.5B -669M -654M -28.36B
Net Debt -458M -396M -371M -339M -637M -43.67B -648M -4.36B -1.7B -21.85B -1.72B -1.68B -72.89B -381M -330M -309M -282M -530M -36.34B -539M -3.62B -1.42B -18.18B -1.43B -1.4B -60.66B
Logo Zai Lab Limited
Zai Lab Ltd is a holding company primarily engaged in biopharmaceutical business. The Company is focused on discovering, developing, and commercializing products that address medical conditions with significant unmet needs in the areas of oncology, immunology, neuroscience, and infectious disease. The Company has a series of patented drug candidates from the discovery stage to the late clinical project, including ZEJULA, OPTUNE, QINLOCK, NUZYRA and VYVGART, and others. The Company conducts its businesses within domestic and overseas markets.
Employees
1,784
Date Price Change Volume
26-08-11 US$26.00 +10.31% 3,809,007
26-08-10 US$23.57 +1.07% 1,698,221
26-08-07 US$23.32 +11.69% 2,046,149
26-08-06 US$20.88 +13.66% 1,388,631
26-08-05 US$18.37 -0.65% 195,278
Trader
Investor
-
Global
-
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
12
Last Close Price
23.57USD
Average target price
32.18USD
Spread / Average Target
+36.54%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ZLAB Stock